Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 23;19(4):e0300582.
doi: 10.1371/journal.pone.0300582. eCollection 2024.

Correlation analysis of serum TLR4 protein levels and TLR4 gene polymorphisms in gouty arthritis patients

Lu Liu  1   2 , Shuang He  3 , Lin Jia  1 , Hua Yao  1 , Dan Zhou  1 , Xiaobin Guo  1 , Lei Miao  2
Affiliations

Correlation analysis of serum TLR4 protein levels and TLR4 gene polymorphisms in gouty arthritis patients

Lu Liu et al. PLoS One. .

Abstract

Objective: The Toll-like receptor (TLR) 4-mediated nuclear factor kappa B (NF-κB) signaling pathway regulates the production of inflammatory factors and plays a key role in the pathogenesis of gouty arthritis. The aim of the present study was to investigate the link among TLR4 gene polymorphisms at various loci, protein expression, and gouty arthritis susceptibility.

Methods: Between 2016 and 2021, a case-control study was used to collect a total of 1207 study subjects, including 317 male patients with gouty arthritis (gout group) and 890 healthy males (control group). The association between gout susceptibility and different genetic models was analyzed by typing three loci of the TLR4 gene (rs2149356, rs2737191, and rs10759932) using a multiplex point mutation rapid assay, and the association between protein expression and gout was confirmed by measuring TLR4 protein concentrations using enzyme-linked immunosorbent assays (ELISAs).

Results: In a codominant models AA and AG, the rs2737191 polymorphism in the gout group increased the risk of gout compared to the AA genotype (OR = 2.249, 95%CI 1.010~5.008), and the risk of gout was higher for those carrying the G allele compared to the A allele (OR = 2.227, 95%CI 1.006~4.932). TLR4 protein expression was different between the two groups with different locus genotypes. The differences in TLR4 protein expression between the gout group and control group were statistically significant between the following genotypes: the GG and GT genotypes of the rs2149356 polymorphism; the AA and AG genotypes of the rs2737191 polymorphism; and the TT and TC genotypes of the rs10759932 polymorphism(P<0.05). The TLR4 protein level in the gout group (19.19±3.09 ng/ml) was significantly higher than that in the control group (15.85±4.75 ng/ml).

Conclusion: The AG genotype of the TLR4 gene rs2737191 polymorphism may be correlated with the development of gouty arthritis. The level of TLR4 protein expression is significantly higher in patients with gouty arthritis than in controls, and there is a correlation between high TLR4 protein expression and the development of gouty arthritis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1
A: Genotyping results of rs2149356, B: Genotyping results of rs2737191, C: Genotyping results of rs10759932.
Fig 2
Fig 2
A: Comparison of TLR4 protein concentration between gout group and control group, B: Comparison of TLR4 protein concentration between different SUA grades.
See this image and copyright information in PMC

References

    1. Lim SY, Lu N, Oza A, Fisher M, Rai SK, Menendez ME, et al.. Trends in gout and rheumatoid arthritis hospitalizations in the United States, 1993–2011. JAMA. 2016;315(21):2345–7. doi: 10.1001/jama.2016.3517 - DOI - PMC - PubMed
    1. Maurano M T, Humbert R, Rynes E, et al..Systematic localization of common disease-associated variation in regulatory DNA.Sciene, 2012,337(6099):1190–5. doi: 10.1126/science.1222794 - DOI - PMC - PubMed
    1. Anagnostopoulos I, Zinzaras E, Alexiou I, Papathanasiou AA, Davas E, Koutroumpas A, et al.. The prevalence of rheumatic diseases in central Greece: a population survey. BMC Musculoskelet Disord, 2010;11:98. doi: 10.1186/1471-2474-11-98 - DOI - PMC - PubMed
    1. Juraschek SP, Miller ER, Gelber AC. Body mass index, obesity, and prevalent gout in the United States in 1988–1994 and 2007–2010[J]. Arthritis Care Res, 2013, 65(1): 127–132. - PMC - PubMed
    1. Kuo CF, Grainge MJ, Mallen C, et al.. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study[J]. Ann Rheum Dis. 2015,74(4): 661–667. - PMC - PubMed

Publication types